Headlands Technologies LLC

Position in ARVN — Arvinas, Inc.

CIK 1570271 CHICAGO, IL

Position in ARVN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$502,223

-$272,032 QoQ

Shares Held

60,436

-17.3% QoQ

Ownership

0.092%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#77

of 198 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Headlands Technologies LLC holds $60,689,199 across 67 Biotechnology names. ARVN ranks #37 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	10,545	$6,575,229
2	RPRX	Royalty Pharma plc	90,729	$5,087,175
3	INSM	INSMED Inc	40,855	$4,355,960
4	BNTX	BioNTech SE	27,087	$2,520,445
5	NAMS	NewAmsterdam Pharma Co N.V.	72,335	$2,451,433
6	IBRX	ImmunityBio, Inc.	248,550	$2,176,055
7	ABCL	AbCellera Biologics Inc.	246,252	$1,933,078
8	NVAX	Novavax Inc	190,547	$1,794,952

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$502,223	60,436	-17.3%	Shares	Sole	2026-08-13
2026-03-31	$774,255	73,043	-15.3%	Shares	Sole	2026-05-13
2025-12-31	$1,022,462	86,211	+569.5%	Shares	Sole	2026-02-13
2025-09-30	$109,712	12,877	-48.5%	Shares	Sole	2025-11-12
2025-03-31	$175,633	25,019	+32.5%	Shares	Sole	2025-05-09
2024-12-31	$362,102	18,889	-2.4%	Shares	Sole	2025-02-12
2024-09-30	$476,467	19,345	+14.9%	Shares	Sole	2024-11-12
2024-06-30	$448,200	16,837	+605.1%	Shares	Sole	2024-08-07
2023-12-31	$98,290	2,388	+393.4%	Shares	Sole	2024-02-02
2023-09-30	$9,505	484	+830.8%	Shares	Sole	2023-11-09
2023-03-31	$1,420	52	—	Shares	Sole	2023-05-01
No filing history on record for this holder in this stock.